查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585678

生物技術設備市場：按產品、最終用戶分類 - 2025-2030 年全球預測

Biotechnology Instrumentation Market by Product (Bioreactors, Centrifuges, Electrophoresis), End-User (Biotechnology & Biopharmaceutical Companies, Clinical Research Organizations (CROs), Government & Academic Institutes) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年生物技術設備市場價值為241.9億美元，預計2024年將達到264.9億美元，複合年成長率為9.84%，到2030年將達到466.7億美元。

生物技術設備市場包括生物技術研究、開發和應用所需的各種設備和工具。其中包括基因組學、蛋白質組學、細胞生物學和診斷測試設備。醫療保健、製藥和農業領域對先進技術的需求不斷成長，以解決疾病診斷、藥物發現和基因改造等複雜的生物挑戰，從而推動了對這些設備的需求。生物技術設備用於多種應用，包括定序、成像、層析法和光譜學，最終用途包括醫學研究機構、製藥公司和實驗室。

主要市場統計
基準年[2023] 241.9億美元
預測年份 [2024] 264.9億美元
預測年份 [2030] 466.7億美元
複合年成長率（%） 9.84%

市場成長受到分子生物學技術進步、生物技術研究資金增加以及個人化醫療需求不斷成長等因素的影響。新的商機在於開發經濟高效、可攜式、高通量的設備以及人工智慧和機器學習的整合以提高資料分析能力。此外，由於一些生物製藥的專利到期，支持生物製藥和生物相似藥開發的設備市場正在擴大。

該市場面臨的挑戰包括與先進設備相關的高成本、複雜的法規環境以及需要高技能人員來操作這些複雜設備。此外，技術創新的快速步伐意味著現有設備很快就會過時，並且存在過時的風險。

設備小型化、實驗室晶片技術開發以及生物感測器靈敏度和特異性的改進等領域正在創新。專注於降低設備成本以及提高生物技術檢測的準確性和速度的研究提供了進一步的成長機會。

生物技術設備市場充滿活力且競爭激烈，其特點是不斷進步並重視研究和開發。能夠駕馭監管環境、響應不斷變化的最終用戶需求並利用技術創新的公司，就能夠充分利用成長潛力並保持其市場地位。

市場動態：揭示快速發展的生物技術設備市場的關鍵市場洞察

供需的動態交互作用正在改變生物技術設備市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 疾病持續增加，需有效治療
    • 擴大攜帶式照護現場診斷設備的採用
    • 改善各國的醫療保健支出和基礎設施
  • 市場限制因素
    • 引進生技設備的初始成本較高
  • 市場機會
    • 實驗室自動化設備的進步
    • 增加對基因組研究計劃和新興企業的投資
  • 市場挑戰
    • 嚴格的監管要求和檢驗流程

波特五力：駕馭生技設備市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解生物技術設備市場的外部影響

外部宏觀環境因素在塑造生物技術設備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解生物技術設備市場的競爭格局

對生物技術設備市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣生物技術設備市場供應商的績效評估

FPNV定位矩陣是評估生物技術設備市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃生物技術設備市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，生物技術設備市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 疾病盛行率持續增加，需要有效的治療方法
      • 擴大採用可攜式照護現場診斷設備
      • 改善整個經濟的醫療保健支出和基礎設施
    • 抑制因素
      • 引進生技設備的初始成本較高
    • 機會
      • 實驗室自動化設備的進步
      • 對基因組研究計劃和Start-Ups的新投資
    • 任務
      • 嚴格的監管要求和檢驗流程
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章生物技術設備市場：依產品

  • 反應器
  • 離心機
  • 電泳
  • 免疫檢測
  • 培養箱
  • 液相層析法
  • 質譜分析
  • 次世代定序
  • 光強度

第7章生物技術設備市場：依最終用戶分類

  • 生物技術和生物製藥公司
  • 臨床研究組織（CRO）
  • 政府和學術機構

第8章美洲生物技術設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太生物技術設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲/中東/非洲生技設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Alcon Scientific
  • Azenta Life Sciences
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Bruker Corporation
  • Danaher Corporation
  • Endress+Hauser Group Services AG
  • F. Hoffmann-La Roche Ltd.
  • GE HealthCare Technologies Inc.
  • HORIBA, Ltd.
  • Hudson Robotics
  • Illumina, Inc.
  • JASCO
  • Lumentum Holdings Inc.
  • Merck KGaA
  • Oxford Nanopore Technologies PLC
  • PerkinElmer US LLC
  • Qiagen GmbH
  • Quest Diagnostics Incorporated
  • Sartorius AG
  • Shimadzu Corporation
  • Siemens Healthcare GmbH
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
Product Code: MRR-521BAA36EA70

The Biotechnology Instrumentation Market was valued at USD 24.19 billion in 2023, expected to reach USD 26.49 billion in 2024, and is projected to grow at a CAGR of 9.84%, to USD 46.67 billion by 2030.

The biotechnology instrumentation market encompasses a wide array of devices and tools essential for the research, development, and application of biotechnology. These include instruments for genomics, proteomics, cell biology, and diagnostic testing. The necessity of these instruments stems from the growing demand for advanced technologies in healthcare, pharmaceuticals, and agriculture to address complex biological challenges, such as disease diagnosis, drug discovery, and genetic modification. Biotech instruments are utilized in various applications, such as sequencing, imaging, chromatography, and spectroscopy, with end-use in medical research institutions, pharmaceutical companies, and laboratories.

KEY MARKET STATISTICS
Base Year [2023] USD 24.19 billion
Estimated Year [2024] USD 26.49 billion
Forecast Year [2030] USD 46.67 billion
CAGR (%) 9.84%

Market growth is influenced by factors such as advancements in molecular biology techniques, increased funding for biotech research, and the rising demand for personalized medicine. Emerging opportunities lie in the development of cost-effective, portable, and high-throughput devices, as well as integrating AI and machine learning to enhance data analysis capabilities. There is also a growing market for instruments that cater to the development of biologics and biosimilars, driven by the expiration of patents for several biologic drugs.

Challenges in the market include high costs associated with advanced instrumentation, the intricate regulatory environment, and the need for highly skilled personnel to operate these complex devices. Furthermore, the rapid pace of technological change can outdate existing instruments quickly, posing a risk of obsolescence.

Innovation is ripe in fields such as miniaturization of devices, development of lab-on-a-chip technologies, and enhancement of biosensor sensitivity and specificity. Research focusing on reducing instrument costs and improving the accuracy and speed of biotechnological assays offers further growth opportunities.

The biotech instrumentation market is dynamic and competitive, characterized by continuous advancements and a strong emphasis on research and development. Companies that can navigate regulatory landscapes, cater to evolving end-user demands, and leverage technological innovations are well-positioned to capitalize on growth potential and sustain their market relevance.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biotechnology Instrumentation Market

The Biotechnology Instrumentation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Continuous rise in prevalence of diseases and need for effective treatments
    • Growing adoption of portable point-of-care diagnostic devices
    • Improved healthcare spending and infrastructure across economies
  • Market Restraints
    • Initial high costs associated with implementation of biotechnology instruments
  • Market Opportunities
    • Growing advancements in lab automation instruments
    • Emerging investments in genomic research projects and startups
  • Market Challenges
    • Stringent regulatory requirements and validation processes

Porter's Five Forces: A Strategic Tool for Navigating the Biotechnology Instrumentation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biotechnology Instrumentation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biotechnology Instrumentation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biotechnology Instrumentation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biotechnology Instrumentation Market

A detailed market share analysis in the Biotechnology Instrumentation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biotechnology Instrumentation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biotechnology Instrumentation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biotechnology Instrumentation Market

A strategic analysis of the Biotechnology Instrumentation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biotechnology Instrumentation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Alcon Scientific, Azenta Life Sciences, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Bruker Corporation, Danaher Corporation, Endress+Hauser Group Services AG, F. Hoffmann-La Roche Ltd., GE HealthCare Technologies Inc., HORIBA, Ltd., Hudson Robotics, Illumina, Inc., JASCO, Lumentum Holdings Inc., Merck KGaA, Oxford Nanopore Technologies PLC, PerkinElmer U.S. LLC, Qiagen GmbH, Quest Diagnostics Incorporated, Sartorius AG, Shimadzu Corporation, Siemens Healthcare GmbH, Tecan Trading AG, Thermo Fisher Scientific Inc., and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Biotechnology Instrumentation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Bioreactors, Centrifuges, Electrophoresis, Immunoassay, Incubators, Liquid Chromatography, Mass Spectrometry, Next Generation Sequencing, and Spectrophotometers.
  • Based on End-User, market is studied across Biotechnology & Biopharmaceutical Companies, Clinical Research Organizations (CROs), and Government & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Continuous rise in prevalence of diseases and need for effective treatments
      • 5.1.1.2. Growing adoption of portable point-of-care diagnostic devices
      • 5.1.1.3. Improved healthcare spending and infrastructure across economies
    • 5.1.2. Restraints
      • 5.1.2.1. Initial high costs associated with implementation of biotechnology instruments
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing advancements in lab automation instruments
      • 5.1.3.2. Emerging investments in genomic research projects and startups
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory requirements and validation processes
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biotechnology Instrumentation Market, by Product

  • 6.1. Introduction
  • 6.2. Bioreactors
  • 6.3. Centrifuges
  • 6.4. Electrophoresis
  • 6.5. Immunoassay
  • 6.6. Incubators
  • 6.7. Liquid Chromatography
  • 6.8. Mass Spectrometry
  • 6.9. Next Generation Sequencing
  • 6.10. Spectrophotometers

7. Biotechnology Instrumentation Market, by End-User

  • 7.1. Introduction
  • 7.2. Biotechnology & Biopharmaceutical Companies
  • 7.3. Clinical Research Organizations (CROs)
  • 7.4. Government & Academic Institutes

8. Americas Biotechnology Instrumentation Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biotechnology Instrumentation Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biotechnology Instrumentation Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies, Inc.
  • 3. Alcon Scientific
  • 4. Azenta Life Sciences
  • 5. Becton, Dickinson and Company
  • 6. Bio-Rad Laboratories, Inc.
  • 7. bioMerieux SA
  • 8. Bruker Corporation
  • 9. Danaher Corporation
  • 10. Endress+Hauser Group Services AG
  • 11. F. Hoffmann-La Roche Ltd.
  • 12. GE HealthCare Technologies Inc.
  • 13. HORIBA, Ltd.
  • 14. Hudson Robotics
  • 15. Illumina, Inc.
  • 16. JASCO
  • 17. Lumentum Holdings Inc.
  • 18. Merck KGaA
  • 19. Oxford Nanopore Technologies PLC
  • 20. PerkinElmer U.S. LLC
  • 21. Qiagen GmbH
  • 22. Quest Diagnostics Incorporated
  • 23. Sartorius AG
  • 24. Shimadzu Corporation
  • 25. Siemens Healthcare GmbH
  • 26. Tecan Trading AG
  • 27. Thermo Fisher Scientific Inc.
  • 28. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. BIOTECHNOLOGY INSTRUMENTATION MARKET RESEARCH PROCESS
  • FIGURE 2. BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIOTECHNOLOGY INSTRUMENTATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIOTECHNOLOGY INSTRUMENTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOTECHNOLOGY INSTRUMENTATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOTECHNOLOGY INSTRUMENTATION MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY INCUBATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SPECTROPHOTOMETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GOVERNMENT & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. AUSTRALIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. AUSTRALIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. CHINA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. CHINA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. INDIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. INDIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. INDONESIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. INDONESIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. JAPAN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. JAPAN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. MALAYSIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. MALAYSIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. PHILIPPINES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. PHILIPPINES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. SINGAPORE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. SINGAPORE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. SOUTH KOREA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. SOUTH KOREA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. TAIWAN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. TAIWAN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. THAILAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. THAILAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. VIETNAM BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. VIETNAM BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. DENMARK BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. DENMARK BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. EGYPT BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. EGYPT BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. FINLAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. FINLAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. FRANCE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. FRANCE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. GERMANY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. GERMANY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. ISRAEL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. ISRAEL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. ITALY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. ITALY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. NETHERLANDS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. NETHERLANDS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. NIGERIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. NIGERIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. NORWAY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. NORWAY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. POLAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. POLAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. QATAR BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. QATAR BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. RUSSIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. RUSSIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SAUDI ARABIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. SAUDI ARABIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. SPAIN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. SPAIN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. SWEDEN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. SWEDEN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. SWITZERLAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. SWITZERLAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. TURKEY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. TURKEY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED ARAB EMIRATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED ARAB EMIRATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED KINGDOM BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED KINGDOM BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. BIOTECHNOLOGY INSTRUMENTATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 108. BIOTECHNOLOGY INSTRUMENTATION MARKET, FPNV POSITIONING MATRIX, 2023